BPC-157 is an experimental peptide widely promoted for tendon, muscle and gut healing. Animal research is extensive, but human evidence is still very limited, and as of October 2026 it is not an FDA-approved drug and not yet on the list of substances pharmacies may routinely compound. At My Concierge MD in Beverly Hills, David Nazarian, MD, a board-certified internist, helps patients understand what is known, what is not, and which proven options may fit their goals.
What Is BPC-157?
BPC-157 (“Body Protection Compound-157”) is a synthetic chain of 15 amino acids based on a sequence found in a protein in human gastric juice. It is usually sold as an injectable or oral product and is popular in fitness and recovery communities for its reputation of speeding healing of tendons, ligaments, muscle and the digestive tract.
What the Research Shows
Most of what is claimed about BPC-157 comes from laboratory and animal studies, largely in rats. Those studies report faster healing of tendon, ligament, muscle and gastrointestinal injuries and effects on blood-vessel growth and nitric oxide signaling.
Human data are a different story. Published human experience is limited to small, uncontrolled reports and early safety work. There are no large randomized controlled trials showing that BPC-157 improves recovery from sports injuries, joint pain or gut disease in people. Animal results often do not translate to humans, so the honest answer is that benefit in patients has not been established.
Possible Risks and Unknowns
- Unknown long-term safety. Without controlled human trials, side effects, dosing and long-term risks are not well defined.
- Blood-vessel growth. BPC-157 appears to promote angiogenesis in animal models. That may help healing, but it raises theoretical questions for people with a history of cancer.
- Product quality. Much of what is sold online is labeled “for research use only,” with no assurance of identity, purity, sterility or dose.
- Sports testing. BPC-157 is prohibited by the World Anti-Doping Agency, which matters for competitive athletes.
FDA and Compounding Status (October 2026)
- In 2023 the FDA placed BPC-157 in “Category 2,” a group of substances it said raised significant safety concerns for compounding.
- In April 2026, BPC-157 was removed from Category 2 along with 11 other peptides after the original nominations were withdrawn. Removal was not an approval.
- In July 2026 the FDA’s Pharmacy Compounding Advisory Committee voted 8 to 6 to recommend adding BPC-157 to the 503A bulk substances list, reviewed for ulcerative colitis. FDA scientists had recommended against it.
- The vote is advisory. The FDA must still complete rulemaking before BPC-157 is formally available for routine pharmacy compounding.
We will update this page as the FDA acts.
How Dr. Nazarian Approaches Injury Recovery
Most patients asking about BPC-157 want to heal an injury faster or get back to training. The first step is an accurate diagnosis: an examination, and imaging such as musculoskeletal ultrasound when it would change the plan. From there, options with stronger evidence may include structured physical therapy and loading programs, treatment of contributing factors such as low vitamin D or iron, sleep and nutrition review, and, for selected tendon and joint problems, regenerative procedures discussed on our regenerative medicine page.
For an overview of peptides with more established medical use, see physician-guided peptide therapy and peptides for recovery. Related compound pages: TB-500 and sermorelin.
BPC-157 Evaluation in Beverly Hills and Los Angeles
Patients from across Los Angeles, including Beverly Hills, Bel Air, Brentwood, Century City, West Hollywood and Santa Monica, see Dr. Nazarian at our office at 9301 Wilshire Blvd in Beverly Hills. A peptide consultation is a full medical evaluation, not a sales visit.
- Consultation. Your goals, the injury or condition you want to treat, prior treatments, medications, supplements and any peptides you have already used.
- Examination and imaging. A focused exam and, for tendon, ligament or joint problems, in-office musculoskeletal ultrasound when it will change the plan.
- Baseline labs. Typically a complete blood count, comprehensive metabolic panel (liver and kidney function), HbA1c, hs-CRP, vitamin D and ferritin.
- Safety screening. Review of personal and family cancer history and age-appropriate cancer screening, because BPC-157 affects blood-vessel growth.
- Benefits and risks discussion. What the research shows, what is unknown, current FDA status and every treatment option, so you can make an informed decision.
- Follow-up. Repeat labs and symptom tracking through Continuous Longevity Intelligence to measure your response.
Book a BPC-157 consultation in Beverly Hills
Typical Peptide Treatment Schedule
When a peptide is part of your plan, Dr. Nazarian typically prescribes it at night, five nights a week, Monday through Friday, with weekends off, for an eight-week course followed by a two-week break so the body does not adapt to it. The specific peptide, dose and length of treatment are discussed individually and adjusted to your labs and response.
Frequently Asked Questions
Where can I get BPC-157 in Los Angeles?
Start with a medical evaluation. At My Concierge MD in Beverly Hills, Dr. Nazarian reviews your history, orders baseline tests, explains the benefits, risks and current FDA status, and discusses treatment options, including BPC-157 through licensed compounding pharmacies as that access is established.
What tests do I need before starting BPC-157?
Most patients need a blood count, metabolic panel, inflammation markers and a cancer screening review. Imaging such as ultrasound is added when an injury is involved.
What is the difference between BPC-157 and TB-500?
Both are promoted for recovery. BPC-157 is a 15-amino-acid peptide studied mostly for tendon, ligament and gut healing in animals. TB-500 is based on thymosin beta-4 and is studied for cell migration and wound repair. They are often discussed together but work through different mechanisms.
How much does BPC-157 treatment cost in Beverly Hills?
Cost depends on the evaluation, lab tests and treatment plan. A new-patient consultation with Dr. Nazarian is $450. Lab tests and any treatment are priced separately, and our team gives you those costs before testing begins.
Is BPC-157 legal?
It is not an FDA-approved drug. After the July 2026 advisory vote, it is moving toward possible inclusion on the compounding list, but that process is not finished. Products sold online as research chemicals are not regulated for human use.
Does BPC-157 work for tendon or knee injuries?
Animal studies are encouraging, but there are no high-quality human trials showing it heals tendon or joint injuries. That is the main reason for caution.
Is oral BPC-157 different from injections?
Both forms are sold. Neither has been tested in large human trials, so claims about which works better are not supported by solid evidence.
Can I discuss BPC-157 at a consultation?
Yes. Dr. Nazarian will review your goals, your injury or condition, the current regulatory status and evidence-based alternatives so you can make an informed decision.
To discuss injury recovery or peptide therapy, schedule a consultation at My Concierge MD in Beverly Hills.
This page is educational and does not replace individual medical advice.
Medically reviewed by David Nazarian, MD on